Adage Capital Partners Gp, L.L.C. An2 Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,000,000 shares of ANTX stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 312,615
219.88%
Holding current value
$1.22 Million
Previous $425,000
220.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANTX
# of Institutions
40Shares Held
13.5MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$7.01 Million6.33% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.6 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.26 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY581KShares$708,6400.89% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny528KShares$644,5260.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $23.7M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...